Comparison of Evolut FX Versus Sapien 3 Ultra Resilia.
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1370 participants.
Also called NCT06470022
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,370 participants
- Sponsor
- Christian Juhl Terkelsen
- Registry
-
NCT06470022
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06470022. Randomized; no masking; primary purpose treatment. Start 2024-08-09 (actual); primary completion 2027-07-14 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Evolut FX Versus Sapien 3 Ultra Resilia.
- Acronym
- COMPARE-TAVI
- Condition
- Aortic Stenosis
- Intervention (Device)
- Medtronic Evolut FX
- Intervention (Device)
- Edwards Sapien 3 Ultra Resilia
- Lead sponsor
- Christian Juhl Terkelsen
- Collaborator
- Department of Clinical Epidemiology, Aarhus University, DK-8200 Aarhus N, Denmark
Record details
- Record id
cardio:ct-nct06470022- Content hash
32f9223d74990672be795bd3050e5cd84f2be49180f850050be35edded28474c